Brought to you by 
CeNeS develops Ares-Serono's fertility drug
12 Apr 2000
Executive Summary
CeNeS Pharmaceuticals (CNS and pain management drugs; controlled-release drug delivery) has agreed to develop a formulation of an Ares-Serono fertility drug candidate using its prolonged release gel systems and injection technologies.
Deal Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CeNeS develops Ares-Serono's fertility drug
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice